This makes personalized treatment planning and ongoing support essential to the success of GLP-1 therapy
A call for accessible tools to unlock single-cell immunometabolism research
David Kaufman, a private practice physician who specializes in MCAS, chronic fatigue syndrome, autoimmune diseases, and chronic infections, has been treating long Covid patients with small doses of tirzepatide at his clinic, the Center for Complex Diseases, in Seattle and Mountain View, California
By leveraging advancements in genomics and molecular diagnostics, personalized approaches can identify unique patient profiles, allowing for the selection of targeted therapies that align with the specific biological mechanisms driving disease in each patient [88]
Understanding your genetic context alongside clinical monitoring can support a more informed dialogue with your provider about whether standard escalation to 2.4 mg aligns with your biology, or whether an intermediate plateau may serve your health goals more effectively
